Medicine
Doxercalciferol 1 mcg capsule
Doxercalciferol 1 mcg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)
Key facts
- Active ingredient (INN)
- Doxercalciferol
- Brand
- Sold under the generic name
- Strength
- 1 mcg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 50 capsules, 30 capsules
- Manufacturers
- Avet PharmaceuticalsIndiaChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H05BX03 Doxercalciferol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 October 2020
- Identifiers
- RxCUI 310023, 406503, 858262DailyMed set ID 2ed2f592-27a7-4c10-a18a-21a3f221d3b1, 356fb38a-791c-48f0-9312-6203ae57d80cNDC 23155-539, 62135-451Application ANDA205360
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 capsule in 1 bottle | 23155-539-25 | Avet PharmaceuticalsIndia | 31 October 2020 |
| 30 capsule in 1 bottle | 62135-451-30 | Chartwell RX | 26 January 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 June 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Doxercalciferol
Clinical summary
Doxercalciferol is a vitamin D2 analog indicated for the treatment of secondary hyperparathyroidism in adult patients with CKD on dialysis Doxercalciferol is a synthetic vitamin D 2 analog. MedsAcross supplies Doxercalciferol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxercalciferolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxercalciferol prescribing information (Alembic Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Doxercalciferol 1 mcg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.